Patent Law

Business | Economy

The Patent Labyrinth: Why Cheaper Meds Are Stuck in Traffic
May 26, 2026

Big Pharma’s favorite maze game? Patents. They claim innovation, yet leave generic drugs entangled in legal red tape longer than a DMV line on…

End of content

Draft Ethics Complaint Flags Khanna’s Family Trust Stock Moves: A 239‑Page Paper Trail in Progress

A draft complaint against Rep. Ro Khanna points to a tangled web of late-stock disclosures and family trust trades timed with legislative influence, spotlighting the delicate dance between public virtue and private billing.

Culture | Tech

YouTube’s Deepfake Detector: Too Little, Too Late—or the Panic Boutique We Needed?

By Holden McGroin

YouTube has launched a visual deepfake detection tool, but with voice scams rising, are we chasing shadows while the real threat creeps in?

Business | Economy

Wall Street’s New Favorite Dance: The Medicare Money Shuffle

By Justin Jest

Picture the dance floor at a swanky Wall Street gala, where every beat syncs perfectly with Medicare's cascading cash flow. It's not a fundraiser—it's…

Crime | Justice

FBI’s ‘Header Horror’: Court Undoes a Redaction Dance

By Hugh Jass

A recent court ruling exposed the quirks of FOIA as the FBI defended its redaction of a death-threat email's metadata on grounds of 'record creation.'

Politics | Sports

Maine Senate Hopeful’s Red Sox Ad Pulled Mid‑Game—Campaigners Cry Sabotage

By Mike Rotch

Graham Platner’s Red Sox game ad slam against private equity got yanked by NESN over IP claims. Now he's pitching it as a win, while critics say it's a smokescreen.

Business | Economy

The Patent Labyrinth: Why Cheaper Meds Are Stuck in Traffic

By Lee Keybum

Big Pharma's favorite maze game? Patents. They claim innovation, yet leave generic drugs entangled in legal red tape longer than a DMV line on…